BDNF and Huntingtin protein modifications by manganese: Implications for striatal medium spiny neuron pathology in manganese neurotoxicity

Journal of Neurochemistry

Volumn 131, Issue 5, 2014, Pages 655-666

  Stansfield, Kirstie H ^a   Bichell, Terry Jo ^b   Bowman, Aaron B ^b   Guilarte, Tomás R ^a  

^a Department of Medicine   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BDNF; Cortical; Huntingtin; Manganese; Medium spiny neuron

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HUNTINGTIN; MANGANESE; HUNTINGTIN PROTEIN, RAT; MICROTUBULE ASSOCIATED PROTEIN; MTAP2 PROTEIN, MOUSE; NERVE PROTEIN; NUCLEAR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN NERVE CELL; CELL ASSAY; CELL FUNCTION; CELL LEVEL; CELL TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE ASSOCIATION; EMBRYO; HIPPOCAMPUS; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NEUROTOXICITY; NONHUMAN; PRIMATE; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL EMBRYO; BRAIN; CELL CULTURE; CYTOLOGY; DENDRITIC SPINE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; INTOXICATION; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; CORPUS STRIATUM; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; MANGANESE; MANGANESE POISONING; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84915827829     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12926     Document Type: Article

References (62)

1. Altar C. A., Cai N., Bliven T., Juhasz M., Conner J. M., Acheson A. L., Lindsay R. M. and Wiegand S. J. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856-860.
2. Aschner J. L. and Aschner M. (2005) Nutritional aspects of manganese homeostasis. Mol. Aspects Med. 26, 353-362.
3. Aschner M., Erikson K. M. and Dorman D. C. (2005) Manganese dosimetry: species differences and implications for neurotoxicity. Crit. Rev. Toxicol. 35, 1-32.
4. Aschner M., Guilarte T. R., Schneider J. S. and Zheng W. (2007) Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 221, 131-147.
5. Banker G. A. and Cowan W. M. (1977) Rat hippocampal neurons in dispersed cell culture. Brain Res. 126, 397-342.
6. Baquet Z. C., Gorski J. A. and Jones K. R. (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J. Neurosci. 24, 4250-4258.
7. Bowman A. B., Kwakye G. F., Herrero Hernandez E. and Aschner M. (2011) Role of manganese in neurodegenerative diseases. J. Trace Elem. Med Biol. 25, 191-203.
8. Brewer L. D., Thibault O., Staton J., Thibault V., Rogers J. T., Garcia-Ramos G., Kraner S., Landfield P. W. and Porter N. M. (2007) Increased vulnerability of hippocampal neurons with age in culture: temporal association with increases in NMDA receptor current, NR2A subunit expression and recruitment of L-type calcium channels. Brain Res. 1151, 20-31.
9. Brucke T., Podreka I., Angelberger P., Wenger S., Topitz A., Kufferle B., Muller C. and Deecke L. (1991) Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J. Cereb. Blood Flow Metab. 11, 220-228.
10. Burton N. C., Schneider J. S., Syversen T. and Guilarte T. R. (2009) Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain. Toxicol. Sci. 111, 131-139.
11. Canals J. M., Pineda J. R., Torres-Peraza J. F., Bosch M., Martin-Ibanez R., Munoz M. T., Mengod G., Ernfors P. and Alberch J. (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci. 24, 7727-7739.
12. Colin E., Zala D., Liot G., Rangone H., Borrell-Pages M., Li X. J., Saudou F. and Humbert S. (2008) Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J. 27, 2124-2134.
13. Dobson A. W., Erikson K. M. and Aschner M. (2004) Manganese neurotoxicity. Ann. N. Y. Acad. Sci. 1012, 115-128.
14. Dodd C. A., Ward D. L. and Klein B. G. (2005) Basal Ganglia accumulation and motor assessment following manganese chloride exposure in the C57BL/6 mouse. Int. J. Toxicol. 24, 389-397.
15. Dube L., Smith A. D. and Bolam J. P. (1988) Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum. J. Comp. Neurol. 267, 455-471.
16. Fusco F. R., Chen Q., Lamoreaux W. J. et al. (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 19, 1189-1202.
17. Fusco F. R., Zuccato C., Tartari M., Martorana A., De March Z., Giampa C., Cattaneo E. and Bernardi G. (2003) Co-localization of brainderived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur. J. Neurosci. 18, 1093-1102.
18. Gauthier L. R., Charrin B. C., Borrell-Pages M. et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127-138.
19. Gerfen C. R. (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 23, S64-S70.
20. Gorell J. M., Johnson C. C., Rybicki B. A., Peterson E. L., Kortsha G. X., Brown G. G. and Richardson R. J. (1999) Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20, 239-247.
21. Guilarte T. R. (2010) Manganese and Parkinson's disease: a critical review and new findings. Environ. Health Perspect. 118, 1071-1080.
22. Guilarte T. R. (2013) Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates. Front. Aging Neurosci. 5, 23.
23. Guilarte T. R., Chen M. K., McGlothan J. L. et al. (2006a) Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 202, 381-390.
24. Guilarte T. R., McGlothan J. L., Degaonkar M., Chen M. K., Barker P. B., Syversen T. and Schneider J. S. (2006b) Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol. Sci. 94, 351-358.
25. Guilarte T. R., Burton N. C., McGlothan J. L. et al. (2008a) Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J. Neurochem. 107, 1236-1247.
26. Guilarte T. R., Burton N. C., Verina T., Prabhu V. V., Becker K. G., Syversen T. and Schneider J. S. (2008b) Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J. Neurochem. 105, 1948-1959.
27. Hemmings H. C., Jr, Nairn A. C., Aswad D. W. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphateregulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus. J. Neurosci. 4, 99-110.
28. Hikida T., Kimura K., Wada N., Funabiki K. and Nakanishi S. (2010) Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66, 896-907.
29. Hofer M., Pagliusi S. R., Hohn A., Leibrock J. and Barde Y. A. (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9, 2459-2464.
30. Huang E. J. and Reichardt L. F. (2003) Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609-642.
31. Kemp J. M. and Powell T. P. (1971) The site of termination of afferent fibres in the caudate nucleus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 262, 413-427.
32. Kessler K. R., Wunderlich G., Hefter H. and Seitz R. J. (2003) Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density. Mov. Disord. 18, 217-218.
33. Kravitz A. V., Freeze B. S., Parker P. R., Kay K., Thwin M. T., Deisseroth K. and Kreitzer A. C. (2010) Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622-626.
34. Kreitzer A. C. (2009) Physiology and pharmacology of striatal neurons. Annu. Rev. Neurosci. 32, 127-147.
35. Leenders K. L., Frackowiak R. S., Quinn N. and Marsden C. D. (1986) Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. Mov. Disord. 1, 69-77.
36. Long Z., Jiang Y. M., Li X. R. et al. (2014) Vulnerability of welders to manganese exposure: a neuroimaging study. Neurotoxicology. doi: 10.1016/j.neuro.2014.03.007. [Epub ahead of print]
37. MacDonald M. E., Ambrose C. M., Duyao, M. P. et al. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971-983.
38. Madison J. L., Wegrzynowicz M., Aschner M. and Bowman A. B. (2011) Gender and manganese exposure interactions on mouse striatal neuron morphology. Neurotoxicology 32, 896-906.
39. Madison J. L., Wegrzynowicz M., Aschner M. and Bowman A. B. (2012) Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PLoS ONE 7, e31024.
40. Milatovic D., Zaja-Milatovic S., Gupta R. C., Yu Y. and Aschner M. (2009) Oxidative damage and neurodegeneration in manganeseinduced neurotoxicity. Toxicol. Appl. Pharmacol. 240, 219-225.
41. Nam J. and Kim K. (2008) Abnormal motor function and the expression of striatal dopamine D2 receptors in manganese-treated mice. Biol. Pharm. Bull. 31, 1894-1897.
42. Neal A. P., Stansfield K. H., Worley P. F., Thompson R. E. and Guilarte T. R. (2010) Lead exposure during synaptogenesis alters vesicular proteins and impairs vesicular release: potential role of NMDA receptor-dependent BDNF signaling. Toxicol. Sci. 116, 249-263.
43. Perl D. P. and Olanow C. W. (2007) The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 66, 675-682.
44. Rauskolb S., Zagrebelsky M., Dreznjak A. et al. (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J. Neurosci. 30, 1739-1749.
45. Rubinsztein D. C., Leggo J., Coles R. et al. (1996) Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet. 59, 16-22.
46. Schneider J. S., Decamp E., Koser A. J., Fritz S., Gonczi H., Syversen T. and Guilarte T. R. (2006) Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res. 1118, 222-231.
47. Schneider J. S., Decamp E., Clark K., Bouquio C., Syversen T. and Guilarte T. R. (2009) Effects of chronic manganese exposure on working memory in non-human primates. Brain Res. 1258, 86-95.
48. Schneider J. S., Williams C., Ault M. and Guilarte T. R. (2013) Chronic manganese exposure impairs visuospatial associative learning in non-human primates. Toxicol. Lett. 221, 146-151.
49. Stansfield K. H., Pilsner J. R., Lu Q., Wright R. O. and Guilarte T. R. (2012) Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2+): implications for an environmental basis of neurodevelopmental disorders. Toxicol. Sci. 127, 277-295.
50. Stephenson A. P., Schneider J. A., Nelson B. C., Atha D. H., Jain A., Soliman K. F., Aschner M., Mazzio E. and Renee Reams R. (2013) Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and Nacetylcysteine. Toxicol. Lett. 218, 299-307.
51. Tepper J. M., Tecuapetla F., Koos T. and Ibanez-Sandoval O. (2010) Heterogeneity and diversity of striatal GABAergic interneurons. Front. Neuroanat. 4, 150.
52. Verina T., Kiihl S. F., Schneider J. S. and Guilarte T. R. (2011) Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 32, 215-226.
53. Verina T., Schneider J. S. and Guilarte T. R. (2013) Manganese exposure induces alpha-synuclein aggregation in the frontal cortex of nonhuman primates. Toxicol. Lett. 217, 177-183.
54. Walaas S. I., Aswad D. W. and Greengard P. (1983) A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamineinnervated brain regions. Nature 301, 69-71.
55. Wegrzynowicz M., Holt H. K., Friedman D. B. and Bowman A. B. (2012) Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese. J. Proteome Res. 11, 1118-1132.
56. Williams B. B., Kwakye G. F., Wegrzynowicz M., Li D., Aschner M., Erikson K. M. and Bowman A. B. (2010a) Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. Toxicol. Sci. 117, 169-179.
57. Williams B. B., Li D., Wegrzynowicz M., Vadodaria B. K., Anderson J. G., Kwakye G. F., Aschner M., Erikson K. M. and Bowman A. B. (2010b) Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. J. Neurochem. 112, 227-237.
58. Zala D., Colin E., Rangone H., Liot G., Humbert S. and Saudou F. (2008) Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum. Mol. Genet. 17, 3837-3846.
59. Zou Y., Qing L., Zeng X. et al. (2014) Cognitive function and plasma BDNF levels among manganese-exposed smelters. Occup. Environ. Med. 71, 189-194.
60. Zuccato C. and Cattaneo E. (2007) Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 81, 294-330.
61. Zuccato C., Ciammola A., Rigamonti D. et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498.
62. Zuccato C., Tartari M., Crotti A. et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76-83.